Mirum Pharmaceuticals, Inc. (MIRM) Free cash flow 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$54.9MFY2025 · since FY2019: -$39.6M → $54.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $54.9M | +488.0% |
| FY2024 | $9.3M | +113.1% |
| FY2023 | -$71.1M | +41.0% |
| FY2022 | -$120.4M | +9.3% |
| FY2021 | -$132.8M | -48.7% |
| FY2020 | -$89.3M | -125.3% |
| FY2019 | -$39.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice